Leukotrienes as therapeutic target in asthma
- 1 August 1995
- Vol. 50 (8) , 615-622
- https://doi.org/10.1111/j.1398-9995.1995.tb02578.x
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.Thorax, 1994
- Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses.Thorax, 1994
- The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmaticsEuropean Respiratory Journal, 1994
- 5-LipoxygenaseAnnual Review of Biochemistry, 1994
- Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.Thorax, 1993
- Morrow-Brown needles revisitedJournal of Allergy and Clinical Immunology, 1993
- Arachidonic Acid Metabolism In Airway Epithelial CellsAnnual Review of Physiology, 1992
- Airway Responsiveness to Leukotrienes C4 and D4 and to Methacholine in Patients with Asthma and Normal ControlsNew England Journal of Medicine, 1986
- Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.Thorax, 1984
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983